en
Acute Leukemia Research and Care Network (ALRCaN)
ALRCaN is a unique space for pediatric and adult AL oncologists worldwide to discuss best practices on an ongoing basis. This weekly collegial gathering allows KOLs and HCPs to share best practices and disseminate knowledge.
Collaborate with colleagues across ped/AYA/adult
“You know at ASH, we each (pediatric AL vs. adult AL) go to our own separate sessions and we don't go to the other discipline's sessions. This meeting is really bringing together pediatric and adult oncologists to discuss AL. There is a lot of overlap in knowledge and we should all share it.”
Why join the Acute Leukemia Research and Care Network?
- Weekly continuous education on the latest in acute leukemias
- Warm and humanitarian group for networking and research collaboration
- Connect with experts for case advice or limited-resource strategies
ALRCaN Upcoming Zoom Sessions
January 7
8PM ART
8PM ART
Journal Club con Scott
Dr. Scott Howard
January 9
9AM ET
9AM ET
Acute lymphoblastic leukemia in children with Down syndrome: unique somatic and germline genomic features
Dr. Karen R Rabin
January 14
8PM ART
8PM ART
Es realmente una recaida? LLA - B pediátrica a los 11 años del diagnóstico primario
Dr. David Garay
January 16
9AM ET
9AM ET
Gene regulatory disruptions impact chemotherapy response in acute lymphoblastic leukemia
Dr. Daniel Savic
January 21
8PM ART
8PM ART
Incorporation of high-quality native E coli asparaginase
Dr. Scott Howard
Dr. Oscar Gonzalez Ramella
Dr. Oscar Gonzalez Ramella
January 23
9AM ET
9AM ET
Cytopenias post CAR T-cells: ALL-Hematotox
Dr. Nirali N. Shah
January 28
8PM ART
8PM ART
Genética de la Leucemia aguda pediátrica: apoyando a los niños brasileros
Dra. Mariana Emericiano
January 30
9AM ET
9AM ET
Journal Club with Scott
Dr. Scott Howard
February 6
9AM ET
9AM ET
CNS directed therapy; no quick fixes
Dr. Ajay Vora
February 13
9AM ET
9AM ET
Novel reinduction strategies for relapsed B-ALL
Dr. Laura E Hogan
February 20
9AM ET
9AM ET
CAR T-Cell Therapy to Transplant: Evolving Therapy for AYA Leukemia.
Dr. Hannah Lust
February 27
9AM ET
9AM ET
Outcomes of adolescent and young adult patients with AML treated on adult versus pediatric protocols
Dr. Ira Kraft
March 6
9AM ET
9AM ET
Integration of Blinatumomab Consolidation to CALGB 10403 in Adults with Philadelphia Negative B-cell ALL
Dr. Jose Tinajero
March 27
9AM ET
9AM ET
Reliable leukemia subtyping with machine learning and conformal prediction?
Dr. Jessica Nordlund
Mariya Lysenkova Wiklander (PhD)
Mariya Lysenkova Wiklander (PhD)
Newly launching ALRCaN Asia Pacific
Building bridges in APAC
- Connecting clinicians, researchers, and young professionals
- Sharing best practices and increasing regional insights across all of Asia Pacific
- Supporting growth of the next generation of hematologists/oncologists
Thank You
ALRCaN would like to thank our 2025 volunteer presenters…
Dr. Ibrahim Aldoss
Dr. Talha Badar
Dr. Lindsay Jo Blazin
Dr. Archie Bleyer
Dr. Katelyn Daniels
Dr. Daniel J. DeAngelo
Dr. Natalie Delrocco
Dr. Pablo Domizi
Dr. Naseema Gangat
Dr. Sergio Giralt
Dr. Leah Goldberg
Dr. Scott Howard
Dr. Richard G James
Dr. Marielle Jensen-Battaglia
Dr. Hagop Kantarjian
Dr. Anjani Kapadia
Dr. Motohiro Kato
Dr. M. Eric Kohler
Dr. Elizabeth Krakow
Dr. Roland P Kuiper
Dr. Akhil Rajendra Kurup
Dr. Elena J. Ladas
Dr. Mark J Levis
Dr. Zhenhua Li
Dr. Melissa Loh
Dr. Marlise R Luskin
Dr. Julie Ma
Dr. Luke D Maese
Dr. Spencer Mangum
Dr. Lori Muffly
Dr. Meghan Murphy
Dr. Corentin Orvain
Dr. Shyam A Patel
Dr. Keith W. Pratz
Dr. Raheel Altaf Raja
Dr. Caner Saygin
Dr. Johannes Schetelig
Dr. Bijal Shah
Dr. Nirali N. Shah
Dr. Sara Silbert
Dr. Jose Tinajero
Dr. Anupam Verma
Dr. Eunice S Wang
Dr. Jonathan A Webster
Dr. Cecilia Cs Yeung
Dr. Satoshi Yoshimura
